BDNF-TrkB Signaling Pathway in Spinal Cord Injury: Insights and Implications
Molecular Neurobiology · 2025-02 · 62 (2) · 1904-1944
DOI: 10.1007/s12035-024-04381-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Neurobiology, online erschienen am 24.07.2024. Verfasst von Hedieh Sadat Shamsnia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, No. 99, Yakhchal, Gholhak, Shariati S…. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Brain-Derived Neurotrophic Factor, Signal Transduction, Receptor, trkB. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 174 Literaturangaben.
Abstract (Originalsprache)
Spinal cord injury (SCI) is a neurodegenerative disorder that has critical impact on patient's life expectance and life span, and this disorder also leads to negative socioeconomic features. SCI is defined as a firm collision to the spinal cord which leads to the fracture and the dislocation of vertebrae. The current available treatment is surgery. However, it cannot fully treat SCI, and many consequences remain after the surgery. Accordingly, finding new therapeutics is critical. BDNF-TrkB signaling is a vital signaling in neuronal differentiation, survival, overgrowth, synaptic plasticity, etc. Hence, many studies evaluate its impact on various neurodegenerative disorders. There are several studies evaluating this signaling in SCI, and they show promising outcomes. It was shown that various exercises, chemical interventions, etc. had significant positive impact on SCI by affecting BDNF-TrkB signaling pathway. This study aims to accumulate and evaluate these data and inspect whether this signaling is effective or not.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, No. 99, Yakhchal, Gholhak, Shariati St, P. O. Box: 19419-33111, Tehran, Iran.
- GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
- Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, No. 99, Yakhchal, Gholhak, Shariati St, P. O. Box: 19419-33111, Tehran, Iran. leila_mohaghegh@yahoo.com.
- GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran. leila_mohaghegh@yahoo.com.
- Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. drmehashemi@gmail.com.
- Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. drmehashemi@gmail.com.
Zitieren
APA
Shamsnia, H. S., Peyrovinasab, A., Amirlou, D., Sirouskabiri, S., Rostamian, F., Basiri, N., Shalmani, L. M., Hashemi, M., Hushmandi, K., & Abdolghaffari, A. H. (2025). BDNF-TrkB Signaling Pathway in Spinal Cord Injury: Insights and Implications. Molecular Neurobiology, 62(2), 1904-1944. https://doi.org/10.1007/s12035-024-04381-4
Vancouver
Shamsnia HS, Peyrovinasab A, Amirlou D, Sirouskabiri S, Rostamian F, Basiri N, et al. BDNF-TrkB Signaling Pathway in Spinal Cord Injury: Insights and Implications. Molecular Neurobiology. 2025;62(2):1904-1944. doi:10.1007/s12035-024-04381-4
BibTeX
@article{Shamsnia2025,
author = {Shamsnia, Hedieh Sadat and Peyrovinasab, Amirreza and Amirlou, Dorsa and Sirouskabiri, Shirin and Rostamian, Fatemeh and Basiri, Nasim and Shalmani, Leila Mohaghegh and Hashemi, Mehrdad and Hushmandi, Kiavash and Abdolghaffari, Amir Hossein},
title = {BDNF-TrkB Signaling Pathway in Spinal Cord Injury: Insights and Implications},
journal = {Molecular Neurobiology},
year = {2025},
volume = {62},
number = {2},
pages = {1904--1944},
doi = {10.1007/s12035-024-04381-4}
}
EUVIMED